HLA-DQA1 and Allergy: A key implication of these results is that individuals carrying the HLA-DQA1*01:02 allele may preferentially present particular peanut-allergenic peptides for immune recognition, so although those individuals are at increased risk for allergy, they may also be at increased likelihood of therapeutic benefit from oral exposure.